Results for "SCN9A gene"
Conditions Encyclopedia Entry 1777540325
** This is an entry on a rare genetic disorder known as **Erythromelalgia**. ## Overview Erythromelalgia is a rare genetic disorder characterized by recurring episodes of burning pain, redness, and heat in the hands and feet. This condition affects approximately 1 in 200,000 people worldwide and is often misdiagnosed or underdiagnosed due to its rarity and nonspecific symptoms. Erythromelalgia can significantly impact a person's quality of life, causing discomfort, pain, and limited mobility. The symptoms of erythromelalgia can vary from person to person, but common complaints include: - **Burning pain** in the hands and feet, often triggered by heat, exercise, or stress - **Redness** and warmth in the affected areas - **Increased heart rate** and **blood pressure** in response to stress or heat - **Numbness** or **tingling** sensations in the hands and feet In some cases, erythromelalgia can be associated with other conditions, such as **migraines**, **fibromyalgia**, or **multiple sclerosis**. ## History/Background Erythromelalgia was first described in the medical literature in 1884 by a German physician named **Carl Werdin**. Initially, the condition was thought to be a variant of **Raynaud's disease**, but it was later recognized as a distinct entity. Over the years, researchers have made significant progress in understanding the genetic and molecular mechanisms underlying erythromelalgia. ## Key Information Erythromelalgia is caused by mutations in the **SCN9A** gene, which codes for a sodium channel protein involved in pain transmission. The condition is inherited in an **autosomal dominant** pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition. There are two main types of erythromelalgia: - **Primary erythromelalgia**: This is the most common form of the condition, caused by mutations in the SCN9A gene. - **Secondary erythromelalgia**: This form of the condition is associated with other underlying medical conditions, such as multiple sclerosis or fibromyalgia. ## Significance Erythromelalgia is a significant condition that affects the quality of life of those affected. While there is no cure for the condition, various treatments can help manage symptoms and improve mobility. These include: - **Medications**: such as **anticonvulsants**, **antidepressants**, and **pain relievers** to manage pain and reduce symptoms - **Lifestyle modifications**: such as avoiding heat, exercising regularly, and managing stress - **Therapeutic options**: such as **cold therapy**, **physical therapy**, and **cognitive behavioral therapy** to improve mobility and manage symptoms **Early diagnosis and treatment** are crucial in managing erythromelalgia and improving quality of life. INFOBOX: - Name: Erythromelalgia - Type: Rare genetic disorder - Date: First described in 1884 - Location: Worldwide - Known For: Recurring episodes of burning pain, redness, and heat in the hands and feet TAGS: Erythromelalgia, rare genetic disorder, SCN9A gene, autosomal dominant, primary erythromelalgia, secondary erythromelalgia, pain management, quality of life, genetic disorder.
Health & MedicineConditions Encyclopedia Entry 1777226233
** This encyclopedia entry is about a rare genetic disorder known as **Erythromelalgia** (EM), a condition characterized by burning pain, heat, and redness in the hands and feet. **CONTENT** ### Overview Erythromelalgia (EM) is a rare genetic disorder that affects the nerves and blood vessels in the hands and feet. It is characterized by recurring episodes of burning pain, heat, and redness in these areas. The condition is often described as feeling like walking on hot coals or having a severe sunburn. Erythromelalgia can be a chronic and debilitating condition, significantly impacting a person's quality of life. The symptoms of EM can vary in severity and frequency, but they often worsen with temperature changes, physical activity, or stress. Some people may experience mild symptoms, while others may experience severe and debilitating pain. In severe cases, EM can lead to skin ulcers, nerve damage, and other complications. ### History/Background Erythromelalgia was first described in the medical literature in the late 19th century. The condition was initially thought to be a rare variant of **Raynaud's disease**, a condition that affects blood flow to the fingers and toes. However, as more cases were reported, it became clear that EM was a distinct condition with its own set of symptoms and characteristics. In the 1960s and 1970s, researchers began to identify the genetic basis of EM. They discovered that the condition was caused by mutations in the **SCN9A** gene, which codes for a sodium channel protein involved in nerve function. This discovery led to a greater understanding of the condition and the development of new treatments. ### Key Information Erythromelalgia is a rare condition, affecting approximately 1 in 200,000 people worldwide. It can occur at any age, but it is most commonly diagnosed in children and young adults. The condition is often inherited in an **autosomal dominant** pattern, meaning that a single copy of the mutated gene is enough to cause the condition. There are two main types of EM: primary and secondary. Primary EM is caused by a genetic mutation, while secondary EM is caused by an underlying medical condition, such as **multiple sclerosis** or **diabetes**. ### Significance Erythromelalgia is a significant condition because it can have a profound impact on a person's quality of life. The chronic pain and discomfort associated with EM can lead to depression, anxiety, and other mental health issues. In addition, the condition can make it difficult to engage in physical activity, work, or participate in social activities. Research into EM has also led to a greater understanding of the underlying biology of pain and nerve function. This knowledge has implications for the treatment of other conditions, such as **neuropathic pain** and **epilepsy**. **INFOBOX:** - **Name:** Erythromelalgia (EM) - **Type:** Rare genetic disorder - **Date:** First described in the late 19th century - **Location:** Worldwide - **Known For:** Chronic pain, heat, and redness in the hands and feet **TAGS:** Erythromelalgia, genetic disorder, rare condition, chronic pain, heat, redness, hands, feet, SCN9A gene, autosomal dominant, primary EM, secondary EM, multiple sclerosis, diabetes, neuropathic pain, epilepsy.
Health & MedicineConditions Encyclopedia Entry 1781379148
** This entry is about the rare genetic disorder known as **Erythromelalgia**, a condition characterized by burning pain, redness, and heat in the hands and feet. ## Overview Erythromelalgia is a rare genetic disorder that affects approximately 1 in 200,000 people worldwide. It is characterized by recurring episodes of burning pain, redness, and heat in the hands and feet. The condition is often described as feeling like walking on hot coals or having a severe sunburn. Erythromelalgia can be a debilitating condition, significantly impacting a person's quality of life. The symptoms of erythromelalgia can vary in severity and frequency. Some people may experience mild episodes, while others may have more severe and frequent episodes. The condition can also be associated with other symptoms, such as headaches, dizziness, and nausea. In some cases, erythromelalgia can be a symptom of an underlying condition, such as a blood disorder or a neurological condition. There are two main types of erythromelalgia: primary and secondary. Primary erythromelalgia is a genetic disorder, while secondary erythromelalgia is caused by an underlying condition. The exact cause of primary erythromelalgia is not fully understood, but it is believed to be related to a mutation in the **SCN9A** gene. Secondary erythromelalgia can be caused by a variety of conditions, including blood disorders, neurological conditions, and certain medications. ## History/Background Erythromelalgia was first described in the medical literature in the late 19th century. However, it was not until the 1960s that the condition was recognized as a distinct entity. In the 1980s, researchers discovered that erythromelalgia was associated with a mutation in the SCN9A gene. This discovery led to a greater understanding of the condition and the development of new treatments. ## Key Information Erythromelalgia is a rare condition, but it can have a significant impact on a person's quality of life. The condition can be managed with medication, lifestyle changes, and in some cases, surgery. Medications used to treat erythromelalgia include **anticonvulsants**, **antidepressants**, and **topical anesthetics**. Lifestyle changes, such as avoiding heat and cold, can also help to manage the condition. In some cases, erythromelalgia can be a symptom of an underlying condition. If left untreated, the underlying condition can lead to serious complications, such as organ damage or even death. Therefore, it is essential to seek medical attention if symptoms persist or worsen over time. ## Significance Erythromelalgia is a rare condition, but it can have a significant impact on a person's quality of life. The condition can be managed with medication, lifestyle changes, and in some cases, surgery. Researchers continue to study the condition to better understand its causes and develop new treatments. INFOBOX: - Name: Erythromelalgia - Type: Rare genetic disorder - Date: First described in the late 19th century - Location: Worldwide - Known For: Recurring episodes of burning pain, redness, and heat in the hands and feet TAGS: Erythromelalgia, rare genetic disorder, burning pain, redness, heat, hands, feet, primary erythromelalgia, secondary erythromelalgia, SCN9A gene, anticonvulsants, antidepressants, topical anesthetics, lifestyle changes, surgery.
Health & MedicineConditions Encyclopedia Entry 1777771685
** This entry is about a rare genetic disorder known as **Erythromelalgia**, a condition characterized by burning pain, redness, and heat in the hands and feet. ## Overview Erythromelalgia is a rare genetic disorder that affects the blood vessels and nerve endings in the hands and feet. It is characterized by a triad of symptoms: burning pain, redness, and heat. The condition is often described as feeling like walking on hot coals or having a severe sunburn. Erythromelalgia can be inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition. However, some cases may be acquired, often as a result of an underlying medical condition or as a side effect of certain medications. People with erythromelalgia may experience a range of symptoms, including: * Burning pain in the hands and feet that can be triggered by heat, exercise, or stress * Redness and warmth in the affected areas * Increased sensitivity to touch and temperature * Tingling or numbness in the hands and feet * Difficulty walking or performing daily activities due to pain and discomfort ## History/Background Erythromelalgia was first described in the medical literature in the late 19th century. However, it was not until the 1960s that the condition was recognized as a distinct medical entity. In the 1980s, researchers identified the genetic mutations responsible for the condition, which led to a better understanding of the underlying causes of erythromelalgia. ## Key Information * **Prevalence:** Erythromelalgia is a rare condition, affecting approximately 1 in 100,000 people worldwide. * **Genetics:** Erythromelalgia is caused by mutations in the SCN9A gene, which codes for a sodium channel protein involved in nerve function. * **Symptoms:** The condition is characterized by a triad of symptoms: burning pain, redness, and heat in the hands and feet. * **Treatment:** There is no cure for erythromelalgia, but various treatments can help manage symptoms, including medications, lifestyle modifications, and alternative therapies. * **Prognosis:** The prognosis for people with erythromelalgia is generally good, with many individuals able to manage their symptoms and lead active lives. ## Significance Erythromelalgia is significant because it highlights the importance of genetic research and the need for better understanding of rare medical conditions. The condition also underscores the importance of early diagnosis and treatment, as prompt intervention can help alleviate symptoms and improve quality of life. INFOBOX: - **Name:** Erythromelalgia - **Type:** Rare genetic disorder - **Date:** First described in the late 19th century - **Location:** Worldwide - **Known For:** Characteristic triad of symptoms: burning pain, redness, and heat in the hands and feet TAGS: Erythromelalgia, rare genetic disorder, burning pain, redness, heat, hands, feet, SCN9A gene, sodium channel protein, nerve function, treatment, prognosis, genetic research, early diagnosis.